Rui Morais

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

Massimiliano Greco, Thomas De Corte, Ari Ercole et al. · Intensive Care Medicine · 2022 · 88 citations · Full text

Medicine, Infectious Diseases, Critical Care Medicine +14

Co-infection and ICU-acquired infection in COVID-19 ICU patients: a secondary analysis of the UNITE-COVID data set

Andrew Conway Morris, Katharina Köhler, Thomas De Corte et al. · Critical Care · 2022 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Critical Care Medicine +14

Predictive value of D-dimer in the clinical outcome of severe COVID19 patients: Are we giving it too much credit?

José Pedro Cidade, Luís Coelho, Vasco Costa et al. · Clinical and Applied Thrombosis/Hemostasis · 2022 · 13 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

Septic shock 3.0 criteria application in severe COVID-19 patients: An unattended sepsis population with high mortality risk

José Pedro Cidade, LM Coelho, Vasco Costa et al. · World Journal of Critical Care Medicine · 2022 · 10 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17